In WT and Gpr35−/− PD mice, our analysis revealed marked enrichment in several neural signaling pathways, including neuroactive ligand–receptor interactions, along with tyrosine and tryptophan metabolic processes. This evidence concerns the gene GPR35 and Parkinson disease.